ema restrict pembrolizumab/atezolizumab usage in urothelial cancer
Published 6 years ago • 144 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:43
pembrolizumab: defining standards of care in urothelial cancer
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:54
a 6-factor prognostic model for urothelial carcinoma patients receiving atezolizumab
-
3:34
abacus trial: preoperative atezolizumab in urothelial carcinoma
-
1:47
atezolizumab in urothelial bladder cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
5:27
imvigor130: atezolizumab with or without chemotherapy in metastatic urothelial cancer
-
2:52
pd-l1 and tmb as biomarkers in the imvigor211 trial of atezolizumab vs. chemo for bladder cancer
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
1:13
saul analysis: atezolizumab in urothelial carcinoma patients
-
3:45
fierce-22 trial: vofatamab with pembrolizumab for urothelial carcinoma
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
2:41
firstline pembrolizumab for metastatic urothelial cancer
-
3:06
urothelial carcinoma trial updates from asco 2018
-
1:20
dr. rosenberg on future use of atezolizumab in bladder cancer
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
1:36
pembrolizumab in urothelial cancer
-
0:47
atezolizumab for tnbc